.Pharmacolibrary.Drugs.ATC.D.D07AA01 .Pharmacolibrary.Drugs.ATC.D.D07AA01| name: | Methylprednisolone |
| ATC code: | D07AA01 | route: | oral |
| n-compartments | 2 |
Methylprednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory and immunosuppressive properties. It is indicated in a variety of conditions including autoimmune diseases, allergic reactions, and as part of chemotherapy regimens. It is approved for medical use and is in current clinical use worldwide.
Pharmacokinetic parameters in healthy adult volunteers after a single oral dose.
Wang, DD, et al., & Li, ZP (2018). Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study. Journal of clinical pharmacy and therapeutics 43(4) 476–483. DOI:10.1111/jcpt.12707 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29766530
Tornatore, KM, et al., & Venuto, RC (1995). Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients. Transplantation 59(5) 729–736. DOI:10.1097/00007890-199503150-00016 PUBMED:https://pubmed.ncbi.nlm.nih.gov/7886801
Mehta, J, et al., & Kaushik, NK (2022). Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review. Frontiers in microbiology 13 813358–None. DOI:10.3389/fmicb.2022.813358 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35242118